Antigen persistence is required throughout the expansion phase of a CD4+ T cell response

Journal of Experimental Medicine

Volumn 201, Issue 10, 2005, Pages 1555-1565

  Obst, Reinhard ^a   Van Santen, Hisse Martien ^a   Mathis, Diane ^a   Benoist, Christophe ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD8 ANTIGEN; GLYCOPROTEIN P 15095; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TETRACYCLINE; THY 1 ANTIGEN;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; EFFECTOR CELL; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; T LYMPHOCYTE ACTIVATION; VACCINATION;

ANIMALS; ANTI-BACTERIAL AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; DENDRITIC CELLS; EPITOPES, T-LYMPHOCYTE; GENE EXPRESSION; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; REPRESSOR PROTEINS; T-LYMPHOCYTE SUBSETS; TETRACYCLINE;

EID: 19344376093     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20042521     Document Type: Article

References (61)

1. Guermonprez, P., J. Valladeau, L. Zitvogel, C. Thery, and S. Amigorena. 2002. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20:621-667.
2. Itano, A.A., and M.K. Jenkins. 2003. Antigen presentation to naive CD4 T cells in the lymph node. Nat. Immunol. 4:733-739.
3. Catron, D.M., A.A. Itano, K.A. Pape, D.L. Mueller, and M.K. Jenkins. 2004. Visualizing the first 50 hr of the primary immune response to a soluble antigen. Immunity. 21:341-347.
4. Huang, A.Y., H. Qi, and R.N. Germain. 2004. Illuminating the landscape of in vivo immunity: insights from dynamic in situ imaging of secondary lymphoid tissues. Immunity. 21:331-339.
5. Trombetta, S.E., and I. Mellman. 2005. Cell biology of antigen processing in vitro and in vivo. Annu. Rev. Immunol. 23:975-1028.
6. Mercado, R., S. Vijh, S.E. Allen, K. Kerksiek, I.M. Pilip, and E.G. Pamer. 2000. Early programming of T cell populations responding to bacterial infection. J. Immunol 165:6833-6839.
7. + T lymphocyte responses. Nat. Immunol. 4:361-365.
8. van Stipdonk, M.J., E.E. Lemmens, and S.P. Schoenberger. 2001. Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat. Immunol. 2:423-429.
9. Wong, P., and E.G. Pamer. 2001. Antigen-independent CD8 T cell proliferation. J. Immunol. 166:5864-5868.
10. Wong, P., and E.G. Pamer. 2004. Disparate in vitro and in vivo requirements for IL-2 during antigen-independent CD8 T cell expansion. J. Immunol. 172:2171-2176.
11. + T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat. Immunol. 2:415-422.
12. Bevan, M.J., and P.J. Fink. 2001. The CD8 response on autopilot. Nat. Immumol. 2:381-382.
13. Curtsinger, J.M., C.M. Johnson, and M.F. Mescher. 2003. CD8 T cell clonal expansion and development of effector function require prolonged exposure to antigen, costimulation, and signal 3 cytokine. J. Immunol. 171:5165-5171.
14. Storni, T., C. Ruedl, W.A. Renner, and M.F. Bachmann. 2003. Innate immunity together with duration of antigen persistence regulate effector T cell induction. J. Immunol. 171:795-801.
15. + T cell clonal expansion. J. Immunol. 168:1682-1689.
16. + T cells. J. Immunol. 168:1723-1729.
17. Gett, A.V., F. Sallusto, A. Lanzavecchia, and J. Geginat. 2003. T cell fitness determined by signal strength. Nat. Immunol. 4:355-360.
18. + T cells is amplified by prolonged T cell antigen receptor triggering. J. Exp. Med. 196:793-803.
19. van Santen, H.M., C. Benoist, and D. Mathis. 2004. Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J. Exp. Med. 200:1221-1230.
20. Urlinger, S., U. Baron, M. Thellmann, M.T. Hasan, H. Bujard, and W. Hillen. 2000. Exploring the sequence space for cetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc. Natl. Acad. Sci. USA. 97:7963-7968.
21. van Santen, H.M., C. Benoist, and D. Mathis. 2000. A cassette vector for high-level reporter expression driven by a hybrid invariant chain promoter in transgenic mice. J. Immunol. Methods. 245:133-137.
22. + T cells: half-life and survival signais in the absence of major histocompatibility complex class II molecules. J. Exp. Med. 191:355-364.
23. Hess, J., A. Werner, T. Wirth, F. Melchers, H.M. Jack, and T.H. Winkler. 2001. Induction of pre-B cell proliferation after de novo synthesis of the pre-B cell receptor. Proc. Natl. Acad. Sci. USA. 98:1745-1750.
24. Böcker, R., and C.J. Estler. 1981. Comparison of distribution of doxycycline in mice after oral and intravenous application measured by a high-performance liquid chromatographie method. Arzneimittelforschung (Drug Res.). 31:2116-2117.
25. Sparwasser, T., E.S. Koch, R.M. Vabulas, K. Heeg, G.B. Lipford, J.W. Ellwart, and H. Wagner. 1998. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. 28:2045-2054.
26. + T cell populations lacking helper function. Nat. Immunol. 6:163-170.
27. Hawiger, D., K. Inaba, Y. Dorsett, M. Guo, K. Mahnke, M. Rivera, J.V. Ravetch, R.M. Steinman, and M.C. Nussenzweig. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194:769-779.
28. Fujii, S., K. Liu, C. Smith, A.J. Bonito, and R.M. Steinman. 2004. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J. Exp. Med. 199:1607-1618.
29. Friedl, P., and M. Gunzer. 2001. Interaction of T cells with APCs: the serial encounter model. Trends Immunol. 22:187-191.
30. Faroudi, M., R. Zaru, P. Paulet, S. Muller, and S. Valitutti. 2003. T lymphocyte activation by repeated immunological synapse formation and intermittent signaling. J. Immunol. 171:1128-1132.
31. Labrecque, N., L.S. Whitfield, R. Obst, C. Waltzinger, C. Benoist, and D. Mathis. 2001. How much TCR does a T cell need? Immunity. 15:71-82.
32. Jelley-Gibbs, D.M., N.M. Lepak, M. Yen, and S.L. Swain. 2000. Two distinct stages in the transition from naive CD4 T cells to effectors, early antigen-dependent and late cytokine-driven expansion and differentiation. J. Immunol. 165:5017-5026.
33. + T cell response to Listeria monocytogenes infection. J. Immunol. 173:5679-5687.
34. Williams, M.A., and M.J. Bevan. 2004. Shortening the infectious period does not alter expansion of CD8 T cells but diminishes their capacity to differentiate into memory cells. J. Immunol. 173:6694-6702.
35. Underbill, D.M., M. Bassetti, A. Rudensky, and A. Aderem. 1999. Dynamic interactions of macrophages with T cells during antigen presentation. J. Exp. Med. 190:1909-1914.
36. Gunzer, M., A. Schäfer, S. Borgmann, S. Grabbe, K.S. Zänker, E.B. Bröcker, E. Kämpgen, and P. Friedl. 2000. Antigen presentation in extracellular matrix: interactions of T cells with dendritic cells are dynamic, short lived, and sequential. Immunity. 13:323-332.
37. Mempel, T.R., S.E, Henrickson, and U.H. von Andrian. 2004. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature. 427:154-159.
38. Miller, M.J., A.S. Hejazi, S.H. Wei, M.D. Cahalan, and I. Parker. 2004. T cell repertoire scanning is promoted by dynamic dendritic cell behavior and random T cell motility in the lymph node. Proc. Natl. Acad. Sci. USA. 101:998-1003.
39. + T cell activation by dendritic cells in lymph nodes. J. Exp. Med. 200:847-856.
40. + effector and memory T cell generation. Nat. Immunol. 4:835-842.
41. + T cells independently of precursor frequency. Clin. Immunol. 113:89-100.
42. + T-cell memory. Nat. Med. 7:913-919.
43. Harrington, L.E., R.R. Most, J.L. Whitton, and R. Ahmed. 2002. Recombinant vaccinia virus-induced T-cell immunity: quantitauon of the response to the virus vector and the foreign epitope. J. Virol. 76:3329-3337.
44. + memory T cells in nonlymphoid tissues express a highly activated phenotype. J. Immunol. 169:6655-6658.
45. Foulds, K.E., L.A. Zenewicz, D.J. Shedlock, J. Jiang, A.E. Troy, and H. Shen. 2002. CD4 and CD8 T cells are intrinsically different in their proliferative responses. J. Immunol. 168:1528-1532.
46. Maini, M.K., N. Gudgeon, L.R. Wedderburn, A.B. Rickinson, and P.C. Beverley. 2000. Clonal expansions in acute EBV infection are detectable in the CD8 and not the CD4 subset and persist with a variable CD45 phenotype. J. Immunol. 165:5729-5737.
47. Rickinson, A.B., and E. Kieff. 2001. Epstein-Barr virus. In Fields Virology. D.M. Knipe and P.M. Howley, editors. Lippincott Williams & Wilkins, Philadelphia. 2575-2627.
48. Tan, J.T., E. Dudl, E. LeRoy, R. Murray, J. Sprent, K.I. Weinberg, and C.D. Surh. 2001. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc. Natl. Acad. Sci. USA. 98:8732-8737.
49. + T cell responses. Curr. Opin. Immunol. 12:448-455.
50. Croft, M. 2003. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat. Rev. Immunol. 3:609-620.
51. Lanzavecchia, A. 1998. Licence to kill. Nature. 393:413-414.
52. Quezada, S.A., L.Z. Jarvinen, E.F. Lind, and R.J. Noelle. 2004. CD40/CD154 interactions at the interface of tolerance and immunity. Annu. Rev. Immunol. 22:307-328.
53. Lover, V., P. Fontaine, S. Pion, F. Hetu, D.C. Roy, and C. Perreault. 1999. The in vivo fate of APCs displaying minor H antigen and/or MHC differences is regulated by CTLs specific for immunodominant class I-associated epitopes. J. Immunol. 163:6462-6467.
54. + T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity. J. Immunol. 164:3095-3101.
55. Ronchese, F., and I.F. Hermans. 2001. Killing of dendritic cells: a life cut short or a purposeful death? J. Exp. Med. 194:F23-F26.
56. Wong, P., and E.G. Pamer. 2003. Feedback regulation of pathogen-specific T cell priming. Immunity. 18:499-511.
57. Miga, A.J., S.R. Masters, B.G. Durell, M. Gonzalez, M.K. Jenkins, C. Maliszewski, H. Kikutani, W.F. Wade, and R.J. Noelle. 2001. Dendritic cell longevity and T cell persistence is controlled by CD154-CD40 interactions. Eur. J. Immunol. 31:959-965.
58. Medema, J.P., D.H. Schuurhuis, D. Rea, J. van Tongeren, J. de Jong, S.A. Bres, S. Laban, R.E.M. Toes, M. Toebes, T.N.M. Schumacher, et al. 2001. Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cells. J. Exp. Med. 194:657-667.
59. + T cells in transgenic mice expressing a class II MHC-restricted antigen receptor. Nature. 341:746-749.
60. Green, E.A., and R.A. Flavell. 2000. The temporal importance of TNFα expression in the development of diabetes. Immunity. 12:459-469.
61. Auffray, C., and F. Rougeon. 1980. Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur. J. Biochem. 107:303-314.